Cargando…
FDA authorized molecular point-of-care SARS-CoV-2 tests: A critical review on principles, systems and clinical performances
Since the start of the COVID-19 pandemic, 10 manufacturers of molecular tests for SARS-CoV-2 have received Emergency Use Authorizations from the U.S. Food and Drug Administration for point-of-care or over the counter use. In this review, the working principle of these tests is described as well as t...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122839/ https://www.ncbi.nlm.nih.gov/pubmed/35619623 http://dx.doi.org/10.1016/j.biosx.2022.100158 |